Literature DB >> 19652600

Low-level population exposure to inorganic arsenic in the United States and diabetes mellitus: a reanalysis.

Craig Steinmaus1, Yan Yuan, Jane Liaw, Allan H Smith.   

Abstract

BACKGROUND: Although studies have reported associations between high concentrations of ingested inorganic arsenic and diabetes mellitus, there is no evidence of this association at low exposures. However, a well-publicized study (JAMA. 2008;300:814-822) recently produced an extraordinary finding of a more than 3-fold increase in diabetes at low concentrations of urinary arsenic. This potentially affects 40 million adults in the United States.
METHODS: We used the same cross-sectional data on urinary arsenic and type 2 diabetes mellitus in 795 adults from the 2003-2004 National Health and Nutrition Examination Survey to assess this evidence.
RESULTS: As in the earlier study, we found an odds ratio (OR) near 1.0 for diabetes, comparing the 80th versus 20th percentiles of urinary total arsenic (OR = 0.88 [95% confidence interval = 0.39-1.97]). This OR increased to above 3.0 when urinary arsenobetaine was added to the logistic risk model. However, this high OR was a statistical artifact because arsenobetaine, which is ingested from fish and is essentially nontoxic, is a part of measured total urinary arsenic. These 2 variables are highly correlated (correlation = 0.80). Because arsenobetaine is a part of total arsenic, it should first be subtracted from total arsenic rather than being added to the statistical model. Doing so yields an OR of 1.15 (0.53-2.50).
CONCLUSION: These findings show no evidence of increased risk of diabetes with arsenic exposure in this dataset. This underscores the importance of valid statistical techniques and careful consideration of scientific plausibility when investigating low-concentration chemical exposures.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19652600     DOI: 10.1097/EDE.0b013e3181b0fd29

Source DB:  PubMed          Journal:  Epidemiology        ISSN: 1044-3983            Impact factor:   4.822


  40 in total

Review 1.  Influence of arsenate and arsenite on signal transduction pathways: an update.

Authors:  Ingrid L Druwe; Richard R Vaillancourt
Journal:  Arch Toxicol       Date:  2010-05-26       Impact factor: 5.153

2.  Seafood intake and urine concentrations of total arsenic, dimethylarsinate and arsenobetaine in the US population.

Authors:  Ana Navas-Acien; Kevin A Francesconi; Ellen K Silbergeld; Eliseo Guallar
Journal:  Environ Res       Date:  2010-11-19       Impact factor: 6.498

3.  Association of low to moderate levels of arsenic exposure with risk of type 2 diabetes in Bangladesh.

Authors:  Wen-Chi Pan; Wei Jie Seow; Molly L Kile; Elaine B Hoffman; Quazi Quamruzzaman; Mahmuder Rahman; Golam Mahiuddin; Golam Mostofa; Quan Lu; David C Christiani
Journal:  Am J Epidemiol       Date:  2013-09-18       Impact factor: 4.897

4.  A dose-response study of arsenic exposure and markers of oxidative damage in Bangladesh.

Authors:  Kristin N Harper; Xinhua Liu; Megan N Hall; Vesna Ilievski; Julie Oka; Larissa Calancie; Vesna Slavkovich; Diane Levy; Abu Siddique; Shafiul Alam; Jacob L Mey; Alexander van Geen; Joseph H Graziano; Mary V Gamble
Journal:  J Occup Environ Med       Date:  2014-06       Impact factor: 2.162

5.  Urinary arsenic and insulin resistance in US adolescents.

Authors:  Qing Peng; Siobán D Harlow; Sung Kyun Park
Journal:  Int J Hyg Environ Health       Date:  2015-03-23       Impact factor: 5.840

6.  Urine arsenic concentration and obstructive pulmonary disease in the U.S. population.

Authors:  Eric D Amster; Jang Ik Cho; David Christiani
Journal:  J Toxicol Environ Health A       Date:  2011

7.  Arsenic exposure, diabetes-related genes and diabetes prevalence in a general population from Spain.

Authors:  Maria Grau-Perez; Ana Navas-Acien; Inmaculada Galan-Chilet; Laisa S Briongos-Figuero; David Morchon-Simon; Jose D Bermudez; Ciprian M Crainiceanu; Griselda de Marco; Pilar Rentero-Garrido; Tamara Garcia-Barrera; Jose L Gomez-Ariza; Jose A Casasnovas; Juan C Martin-Escudero; Josep Redon; F Javier Chaves; Maria Tellez-Plaza
Journal:  Environ Pollut       Date:  2018-02-21       Impact factor: 8.071

8.  Arsenic exposure, diabetes prevalence, and diabetes control in the Strong Heart Study.

Authors:  Matthew O Gribble; Barbara V Howard; Jason G Umans; Nawar M Shara; Kevin A Francesconi; Walter Goessler; Ciprian M Crainiceanu; Ellen K Silbergeld; Eliseo Guallar; Ana Navas-Acien
Journal:  Am J Epidemiol       Date:  2012-10-24       Impact factor: 4.897

9.  The Association of Arsenic Exposure and Arsenic Metabolism With the Metabolic Syndrome and Its Individual Components: Prospective Evidence From the Strong Heart Family Study.

Authors:  Miranda J Spratlen; Maria Grau-Perez; Lyle G Best; Joseph Yracheta; Mariana Lazo; Dhananjay Vaidya; Poojitha Balakrishnan; Mary V Gamble; Kevin A Francesconi; Walter Goessler; Shelley A Cole; Jason G Umans; Barbara V Howard; Ana Navas-Acien
Journal:  Am J Epidemiol       Date:  2018-08-01       Impact factor: 4.897

10.  Rejoinder: Arsenic exposure and prevalence of type 2 diabetes: updated findings from the National Health Nutrition and Examination Survey, 2003-2006.

Authors:  Ana Navas-Acien; Ellen K Silbergeld; Roberto Pastor-Barriuso; Eliseo Guallar
Journal:  Epidemiology       Date:  2009-11       Impact factor: 4.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.